The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma.

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Abstract Text:

PURPOSE: Treatment in patients with seminoma who have residual or recurrent masses following chemotherapy is still a matter of debate. Surgical resection is currently the most common recommendation for masses greater than 3 cm, resulting in overtreatment in up to 70% of those affected. We analyzed the accuracy of preoperative positron emission tomography for predicting viable tumor residuals in patients with seminoma. MATERIALS AND METHODS: In a prospective, multicenter trial computerized tomography and FDG (2-(F-18)-fluoro-2-deoxy-D-glucose) positron emission tomography were performed before surgical resection for residual or recurrent masses in 20 patients who had undergone chemotherapy for stage IIb, IIc or III seminoma. Histopathological findings were directly correlated with positron emission tomography results. RESULTS: Of the patients 18 presented with residual masses and 2 had recurrent masses following chemotherapy. Histopathological assessment revealed viable tumor in 3 patients and benign lesions in 17. All patients with viable tumor were identified correctly by positron emission tomography. No false-negative results were observed but 9 patients had false-positive positron emission tomography results. This resulted in a negative predictive value of 1 (95% CI 0.63-1) and a positive predictive value of 0.25 (95% CI 0.05-0.57) for FDG-positron emission tomography in our patient cohort. CONCLUSIONS: Our data indicate that FDG-positron emission tomography is capable of excluding viable disease in residual masses, even those exceeding 3 cm. Therefore, it may be considered an additional tool to improve patient counseling. However, the decision to perform surgical resection of the residual mass should not be based exclusively on a positive positron emission tomography image since false-positive results appear to be common.

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of urology

VOLUME: 179

Page Numbers: 936-40

Journal Abbreviation: J. Urol.

ISSN: 1527-3792

DAY: 22

MONTH: 01

YEAR: 2008

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376374

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma.

AFFILIATION: Department of Urology, Charité Campus Benjamin Franklin, Universitaetsmedizin Berlin, Berlin, Germany.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma Related Publications

• 'Persistent' annular erythema of infancy.
• Allelic variation in the effector genes of the tomato pathogen Cladosporium fulvum reveals different modes of adaptive evolution.
• Connexin45 cannot replace the function of connexin40 in conducting endothelium-dependent dilations along arterioles.
• Cortisol effects of D-amphetamine relate to traits of fearlessness and aggression but not anxiety in healthy humans.
• Cost-utility analysis to control Campylobacter on chicken meat: dealing with data limitations.
• Effectiveness and costs of implementation strategies to reduce acid suppressive drug prescriptions: a systematic review.
• Effects of sleep deprivation on impulsive behaviors in men and women.
• Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals.
• Familial occurrence of confluent and reticulated papillomatosis.
• Front fingering and complex dynamics driven by the interaction of buoyancy and diffusive instabilities.
• Gap junctions synchronize vascular tone within the microcirculation.
• How plants recognize pathogens and defend themselves.
• Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells.
• Menstrual cycle phase and responses to drugs of abuse in humans.
• Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.
• Norepinephrine transporter gene variation modulates acute response to D-amphetamine.
• Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
• Personality and gender differences in effects of d-amphetamine on risk taking.
• Resolution matching in a retinal scanning display.
• Seasickness; (motion sickness) a labyrinthological study.
• Serotonin transporter genotype and acute subjective response to amphetamine.
• The composition of serval (Felis serval) milk during mid-lactation.
• The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma.
• Universal hepatitis B vaccination.
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]